Manulife (Manufacturers Life Insurance)’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$141K	Sell	32,199 -3,433	-10%	-$16.2K	﹤0.01%	2551
2025 Q4	$180K	Sell	35,632 -5,081	-12%	-$23.6K	﹤0.01%	2573
2025 Q3	$141K	Sell	40,713 -3,728	-8%	-$14K	﹤0.01%	2695
2025 Q2	$151K	Buy	44,441 +379	+0.9%	+$1.26K	﹤0.01%	2654
2025 Q1	$177K	Sell	44,062 -1,118	-2%	-$5.79K	﹤0.01%	2528
2024 Q4	$293K	Sell	45,180 -1,560	-3%	-$9.29K	﹤0.01%	2460
2024 Q3	$259K	Sell	46,740 -17,263	-27%	-$97.9K	﹤0.01%	2549
2024 Q2	$357K	Buy	64,003 +2,460	+4%	+$14.8K	﹤0.01%	2340
2024 Q1	$413K	Buy	61,543 +1,748	+3%	+$13.8K	﹤0.01%	2274
2023 Q4	$545K	Sell	59,795 -739	-1%	-$4.65K	﹤0.01%	2137
2023 Q3	$334K	Buy	60,534 +11,251	+23%	+$90.2K	﹤0.01%	2319
2023 Q2	$421K	Buy	49,283 +3,126	+7%	+$28K	﹤0.01%	2146
2023 Q1	$424K	Buy	46,157 +220	+0.5%	+$2.37K	﹤0.01%	2107
2022 Q4	$469K	Buy	45,937 +395	+0.9%	+$5.31K	﹤0.01%	2036
2022 Q3	$670K	Sell	45,542 -674	-1%	-$8.75K	﹤0.01%	1798
2022 Q2	$496K	Buy	46,216 +7,343	+19%	+$73.1K	﹤0.01%	2068
2022 Q1	$419K	Buy	38,873 +28,481	+274%	+$385K	﹤0.01%	2302
2021 Q4	$170	Buy	+10,392	New	+$218K	﹤0.01%	2951